HWM
APTO

HighMark Wealth Management’s Aptose Biosciences, Inc. APTO Stock Holding History

HighMark Wealth Management’s Portfolio APTO Stock Details APTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-9
Closed -$28 – 644
2025
Q1 		$28 Sell
9
-1
-10% -$5 ﹤0.01% 571
2024
Q4 		$68 Hold
10
– – ﹤0.01% 565
2024
Q3 		$123 Hold
10
– – ﹤0.01% 574
2024
Q2 		$228 Hold
10
– – ﹤0.01% 560
2024
Q1 		$498 Hold
10
– – ﹤0.01% 526
2023
Q4 		$762 Hold
10
– – ﹤0.01% 523
2023
Q3 		$840 Hold
10
– – ﹤0.01% 512
2023
Q2 		$1.39K Hold
10
– – ﹤0.01% 483
2023
Q1 		$2.89K Hold
10
– – ﹤0.01% 464
2022
Q4 		$2.62K Hold
10
– – ﹤0.01% 406
2022
Q3 		$3K Hold
10
– – ﹤0.01% 410
2022
Q2 		$3K Buy
+10
New +$4.78K ﹤0.01% 419
2022
Q1 		– Sell
-10
Closed -$6K – 550
2021
Q4 		$6K Buy
+10
New +$9.4K ﹤0.01% 352
2021
Q3 		– Sell
-11
Closed -$17K – 531
2021
Q2 		$17K Buy
+11
New +$24K 0.01% 202
2021
Q1 		– Sell
-5
Closed -$10K – 520
2020
Q4 		$10K Buy
+5
New +$11.7K 0.01% 240

Other funds holding APTO

DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
GG
Gleason Group Prospect, Kentucky $1.15B AUM 21.11% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return
CSC
Caldwell Sutter Capital Sausalito, California $246M AUM 23.62% 1-Year Est. Return

HighMark Wealth Management's APTO Position: Q2 2025 in Review

HighMark Wealth Management sold out of Aptose Biosciences, Inc. (APTO) in Q2 2025, closing a stake of 9 shares — an estimated $28 sold.

HighMark Wealth Management first reported a position in APTO in Q4 2020 and held it in 15 quarters. The position peaked at $17K in Q2 2021. 4 funds tracked by Wall St. Rank hold APTO as of Q2 2025.

  • HighMark Wealth Management reported no remaining Aptose Biosciences, Inc. position as of Q2 2025 after selling out during the quarter.
  • HighMark Wealth Management sold 9 Aptose Biosciences, Inc. shares in Q2 2025, an estimated $28.
  • HighMark Wealth Management first reported a position in Aptose Biosciences, Inc. in Q4 2020 and held it in 15 quarters.
  • HighMark Wealth Management's Aptose Biosciences, Inc. position peaked at $17K in Q2 2021.
  • 4 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q2 2025.

Based on HighMark Wealth Management's 13F filing for Q2 2025, filed 21 Jul 2025.